Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Costco eyes 11.3% EPS growth in 2025, Chubb boosts income outlook, and Cigna posts strong Q1 as Zacks spotlights five standout stocks. On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...

Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...

The Cigna Group’s (NYSE:CI) strategic departure from the Medicare […] On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390.